Revenue and Net Revenue Growth
Total revenues increased 14% year over year to $166.3 million; revenues before reimbursements (net revenues) rose 10% to $151.8 million in Q1 2026.
Profitability Expansion
Net income increased 11% to $29.6 million and diluted EPS increased 13% to $0.59 versus $0.52 a year ago; EBITDA grew 15% to $43.1 million with an EBITDA margin of 28.4% (up from 27.3% a year ago).
Operational Productivity and Pricing
Billable hours rose ~6% to approximately 399,000; average technical FTEs increased 5% to 1,013; utilization improved to 76% (from 75% prior year); realized rate increases were approximately 4% year over year.
Capital Return to Shareholders
Returned capital via $16.6 million in dividends and $79 million of share repurchases at an average price of $68.09 in the quarter; the company repurchased ~$177 million over the last four quarters (~5% of shares) and the board approved an additional $50 million repurchase authorization.
Segment Performance and Diversification
Engineering and other scientific segment (85% of net revenues) grew 12% driven by user research (consumer electronics/AI) and utility risk work; environmental & health (15% of net revenues) grew 2%, driven by regulatory consulting in chemicals — company highlights diversified demand across AI-enabled devices, energy, data centers, robotics, and medical devices.
Balanced, Forward-Looking Guidance
Company maintained its FY 2026 guidance: expects net revenues to grow in the high-single digits, full-year EBITDA margin of 27.6%–28.1%, average technical FTEs up ~5% year over year, and realized rate increases of 3%–3.5% for Q2 and FY 2026.
Investment in Talent and Capabilities
Continued recruiting and retention resulted in ~5% technical headcount growth and reported strong offer acceptance rates; stock-based compensation investments aim to attract and retain specialized multidisciplinary talent (FY stock-based comp guide $27.9M–$28.4M).